Prolonged Sense of Smell after COVID-19 Attributed to Persistent Immune Assaults
A new study shows that those whose sense of smell never returned after COVID-19 are under constant immune attacks
Treatments
New Class of Antibiotics Active Against a Wide Range of Bacteria
Dual-acting immuno-antibiotics block an essential pathway in bacteria and activate the adaptive immune response
Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing
The CTS Rotea system is the first Gibco instrument for cell therapy processing applications
Remdesivir for COVID-19: FDA Approved but Still Unproven
Researchers say effective public health strategies are more urgently needed
Study: Prescribed CBD Could Help People Quit Cannabis
Recent research shows that participants treated with CBD showed lower levels of cannabis in their urine and an increased number of days abstinent
Old Drug Standards Delay New Drug Approvals
Early approvals for new treatments, such as those for COVID-19, could get delayed by the standards the FDA used for older drugs, according to a new study
New Models of COVID-19 Spike Protein Could Be Key to Vaccine
The protein structure facilitates viral entry into host cells making it a key target for vaccine and antiviral drug development, according to the researchers
Benefits of Convalescent Plasma for COVID-19 Still Unclear
Despite some anecdotal evidence, scientists still don't have high-quality data showing that the treatment actually works
A Rapid Antiviral Response Platform to Prevent Future Pandemics
Independent research institute in Heidelberg, Germany, to develop an arsenal of new antiviral drug discovery, development and mass-manufacturing tools
AI Vivo Seeks Collaboration Partners to Progress Top-Ranked COVID-19 Therapeutic Candidates
Forty-one of the candidate drugs from AI VIVO’s top-ranked list for COVID-19 are now in clinical trials for COVID-19 by multiple groups globally